Metapharm-cro

YOUR CRO OF CHOICE FOR WOMEN’S HEALTH

WOMEN’S HEALTH

MetaPharm Inc. International is an international contract research organization (CRO) with a proven track record in successfully delivering phase I through phase IV studies in all major indications, including pediatric trials, orphan drugs, biologics, and medical devices, non-interventional studies (NIS), and post-authorization studies. Using our close connections with leading investigators and key opinion leaders, we believe in providing the highest quality solutions worldwide.

For the last 5 years, MetaPharm Inc. has been at the forefront of delivering trials in Women’s Health, focusing on the many unmet medical needs and working to improve existing drug and device therapies in both reproductive health, age-related conditions, and other indications.

EXPERIENCE IN WOMEN’S HEALTH

ART, e.g. IVF, ICSI

Endometriosis

Contraception

Postmenopausal Complaints

Vulvar and Vaginal Atrophy

Vaginitis

Rheumatoid Arthritis

Fibromyalgia Syndrome (FMS)

Polymyalgia Rheumatica

Oncology

Pain Management

Obstetrics

STUDY DESIGN AND  
MANAGEMENT

By utilizing more than two decades of industry experience, coupled with the professional experience of our staff, MetaPharm Inc. provides a well-established approach for successful Women’s Health trials.

HERE’S WHAT SETS US APART:

  • Highly experienced project team
  • Specific clinical Women’s Health study expertise gathered over more than 20 years of experience
  • Strong global network of investigators in Women ́s Health
  • Expertise in implementing advanced technology solutions improving study outcomes
  • Anticipation and contingency planning to avoid pitfalls which only experience can predict
ACCURATE AND APPROPRIATE  
FEASIBILITY

Recruitment is pivotal in achieving the desired outcome of a study. The MetaPharm Inc. team is highly experienced in developing therapeutically appropriate and insightful feasibility questionnaires and extrapolating this to our enrollment plans. Our teams recognize that feminine healthcare has considerable variability in different settings across countries and local cultures, thereby requiring sensitivity and local knowledge. MetaPharm Inc. therefore conducts a feasibility survey to confirm projected recruitment rates and utilizes feedback from local Principal Investigators (PI) as part of our standard proposal process.

SITE TRAINING AND  
QUALIFICATION

MetaPharm Inc. project teams are experts in the design and delivery of site training to ensure protocol-consistent enrolment and efficacy assessments, using electronic data capture systems (EDC, eCOA e.g., ePRO) and innovative study tools including our own project management tool.